SCHEMBL22462015

SCHEMBL22462015

NCCCCC(NC(=O)C(Cc1cnc[nH]1)NC(=O)CN)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SLC15A2 Q16348 1/20 1.00
▸ CPB2 Q96IY4 3/20 0.54
▸ SLC6A5 Q9Y345 1/20 0.48
▸ ITGB2 P05107 3/20 0.47
▸ ICAM1 P05362 3/20 0.47
▸ ITGAL P20701 3/20 0.47
▸ CPB1 P15086 1/20 0.46
▸ GHSR Q92847 1/20 0.46
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ SLC7A5 Q01650 1/20 0.45
▸ REN P00797 2/20 0.45
▸ EPHX2 P34913 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19087235 1.00 SLC15A2 (1.00) SLC15A2CPB2SLC6A5ITGB2ICAM1
SCHEMBL30175135 1.00 SLC15A2 (1.00) SLC15A2CPB2SLC6A5ITGB2ICAM1
SCHEMBL25354642 0.99 SLC15A2 (0.98) SLC15A2CPB2SLC6A5ITGB2ICAM1
SCHEMBL28851961 0.99 SLC15A2 (0.98) SLC15A2CPB2SLC6A5ITGB2ICAM1
Acetic Acid SCHEMBL31696243 0.97 SLC15A2 (0.94) SLC15A2CPB2SLC6A5ITGB2ICAM1
SCHEMBL29349986 0.97 SLC15A2 (0.94) SLC15A2CPB2SLC6A5ITGB2ICAM1
SCHEMBL29352785 0.96 SLC15A2 (0.92) SLC15A2CPB2SLC6A5ITGB2ICAM1
Acetic Acid SCHEMBL29360257 0.96 SLC15A2 (0.92) SLC15A2CPB2SLC6A5ITGB2ICAM1
SCHEMBL29351224 0.96 SLC15A2 (0.92) SLC15A2CPB2SLC6A5ITGB2ICAM1
SCHEMBL29397091 0.90 SLC15A2 (0.82) SLC15A2CPB2SLC6A5ITGB2ICAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119600198-A Three-dimensional sight redirecting method based on nerve radiation field 南京理工大学 2025-03-11 — — CN claimed
US-20260053753-A1 A DELIVERY SYSTEM COMPRISING SILICON-CONTAINING MATERIAL SISAF LIMITED (GB) 2026-02-26 — — US disclosed
US-12472150-B2 Delivery system comprising silicon-containing material SISAF LIMITED (GB) 2025-11-18 — — US disclosed
US-12465592-B2 Structured encapsulated silicon-containing particles SISAF LIMITED (GB) 2025-11-11 — — US disclosed
EP-3946257-B1 A DELIVERY SYSTEM COMPRISING SILICON-CONTAINING MATERIAL SISAF LTD (GB) 2025-08-27 — — EP disclosed
EP-3313258-B1 TISSUE MAPPING AND VISUALIZATION SYSTEMS BOSTON SCIENT SCIMED INC (US) 2025-07-30 — — EP disclosed
EP-3946279-B1 STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES SISAF LTD (GB) 2025-07-23 — — EP disclosed
CN-119600198-A Three-dimensional sight redirecting method based on nerve radiation field 南京理工大学 2025-03-11 — — CN disclosed
CN-118818570-A Method and device for estimating satellite clock error when observed data is missing 中移(上海)信息通信科技有限公司 2024-10-22 — — CN disclosed
CN-115669673-B Application of notoginsenoside Fe and/or notoginsenoside Fd in preparing plant source bactericide and preventing and treating agricultural fungal diseases 澳门大学 2024-06-21 — — CN disclosed
US-11439298-B2 Surface mapping and visualizing ablation system BOSTON SCIENTIFIC SCIMED, INC. (US) 2022-09-13 — — US disclosed
US-20220184038-A1 STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES SISAF LIMITED (GB) 2022-06-16 — — US disclosed
US-20220183989-A1 A DELIVERY SYSTEM COMPRISING SILICON-CONTAINING MATERIAL SISAF LIMITED (GB) 2022-06-16 — — US disclosed
EP-3946279-A1 STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES Sisaf Ltd (GB) 2022-02-09 — — EP disclosed
CN-113645957-A Delivery system comprising silicon-containing material SISAF有限公司 2021-11-12 — — CN disclosed
WO-2020193998-A1 STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES SISAF LIMITED (GB) 2020-10-01 — — WO disclosed
EP-3714879-A1 STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES Sisaf Ltd (GB) 2020-09-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12465592-B2 Structured encapsulated silicon-containing particles SGMS1, SGMS2, SMURF1 SLC15A2 4190/4885CPB2 4493/4885SLC6A5 4774/4885
US-20220184038-A1 STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES SGMS1, SGMS2, SMURF1 SLC15A2 4190/4885CPB2 4493/4885SLC6A5 4774/4885
US-20260053753-A1 A DELIVERY SYSTEM COMPRISING SILICON-CONTAINING MATERIAL SMS, SMURF1, SGMS1 SLC15A2 497/4885CPB2 4074/4885SLC6A5 603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback